GlassScriptPhysician profile
Victoria Garcia
NPI 1891866331
$10,524.13
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $58.98 · 2021: $10K · 2022: $25.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,980.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $189.97 | 2020-2021 | |
| Minerva Surgical, INC | $90.61 | 2019 | |
| Genentech USA, INC. | $66.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.17 | 2019-2021 | |
| Cook Medical LLC | $25.32 | 2022 | |
| Glaxosmithkline, LLC. | $20.82 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.42 | 2021 | |
| Abbvie INC. | $19.56 | 2019 | |
| Organon LLC | $13.24 | 2021 | |
| Astellas Pharma US INC | $12.62 | 2019 | |
| Merck Sharp & Dohme LLC | $12.44 | 2019 | |
| Clovis Oncology, INC. | $10.70 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.